UNC Pancreas Center
@UNCPancreas
Official Twitter account for the UNC Lineberger Pancreatic Cancer Center of Excellence #uncpancreas
Investigators from 13 #GICancer SPOREs joined us @UNC_Lineberger this month to share findings from their SPORE-supported research. Thanks to @theNCI for helping us bring together so many brilliant minds to collaborate in one room. Together we progress! go.unc.edu/Dw2z8
Read up on the exciting #pancreaticcancer projects funded by the @UNC_Lineberger Career Enhancement Program in the first two years of our @theNCI SToP Cancer SPORE grant, including @JJMilnerLab work on molecular regulation of T cell activity in PDAC go.unc.edu/x5K9X
There's no Pancreatic Cancer Research Program this year (😡) BUT #pancreaticcancer is included among the Peer Reviewed Cancer Research Program topic areas - so please apply and spread the word!
ATTN Researchers! ‼️ The Congressionally Directed Medical Research Program at the Department of Defense has announced five funding opportunities are now available through the FY25 Peer Reviewed Cancer Research Program (PRCRP), with pancreatic cancer as a topic area. This is…
Excited to share the first of many works out of @JJMilnerLab. Be sure to check it out! Enhancer-driven gene regulatory networks reveal transcription factors governing T cell adaptation and differentiation in the tumor microenvironment: Immunity cell.com/immunity/fullt…
“After going through the process of treatment with him and realizing how few options there were for pancreatic cancer patients … I felt like I was in a position to potentially make a difference with the training that I had" UNC Lineberger's Kirsten Bryant (@bryant_kl), PhD,…
🎉 Congrats to our outstanding @UNC_SOM @ConquerCancerFd awardees 🏅 Dr. @ChemtaiMungo – Career Development Award 🏅 Dr. Yash Agrawal – Young Investigator Award (YIA) 🏅 Dr. @leejae_j – YIA We’re proud to see your impactful research honored on the national stage! @UNC_Lineberger
Congratulations to this year’s class of Conquer Cancer grant and award recipients! Are you one of them? Tell us in the comments! We can't wait to celebrate with you at #ASCO25. Full list of recipients: brnw.ch/21wSR0A @ASCO
Check out some highlights from the innovative #pancreaticcancer projects funded by the @UNC_Lineberger Developmental Research Program in the first two years of our @theNCI SToP Cancer SPORE grant 🔬📔 go.unc.edu/f5DCp
UNC Lineberger researchers and colleagues have discovered an important overlap in genes regulated by the activity of three proteins that support the growth of pancreatic cancer. #UnitedByCancerResearch #NCRM25 @UNCPancreas unclineberger.org/news/new-drug-…
Our team was well repped at #AACR2025, including three posters on #pancreaticancer research from @YehlabUNC members Sandy Zarmer, Maddy Jenner, and Mariaelena Nabors, the last of whom received an AACR-Minority Scholar in Cancer Research Award!
At #AACR25 this afternoon, Madison Jenner will present during the poster session: (Poster 24) Patient-derived cell line and organoid drug screening identifies synergistic PLK1 inhibitor in combination with senolytic ABT-263 for pancreatic cancer. @UNCPancreas ⌚️: 2 – 5 p.m. CT…
At #AACR25 this morning, Brandon L. Mouery, PhD will present during the poster session: LB288 / 11 - Determination of the MYC- and TEAD-dependent transcriptome in pancreatic ⌚️: 9 a.m. - 12 p.m. 📍: South Hall A unclineberger.org/news/unc-lineb…
Jen Jen Yeh (@YehlabUNC), MD, will present today at #AACR25 on the role of surgery in modern cancer treatment: opportunity for patient-derived models or simply an art of diminishing return (pancreatic cancer) @UNCPancreas ⌚️: 5:40 - 6 p.m. 📍: E352 unclineberger.org/news/unc-lineb…
Beautiful day for #PurpleStride. So proud of UNC's Running RAScals and our recording breaking year. @UNC_Lineberger @YPGlab @UNCPancreas @derlabunc
At #AACR25, Mariaelena Nabors will present during the poster session: (Poster 5) Cingulin plays a role in PDAC organoid polarity and subtype. ⌚️: 2 – 5 p.m. CT 📍: South Hall A unclineberger.org/news/unc-lineb…
Today at #AACR25, Sandra Zarmer will present during the poster session: (Poster 6) Identifying vulnerabilities in basal-like pancreatic adenocarcinoma (PDAC) ⌚️: 2 – 5 p.m. CT 📍: South Hall A unclineberger.org/news/unc-lineb…
The UNC running RAScals showed up strong at the @PanCAN Purple Stride, raising more than $25,000 for pancreatic cancer research and support! 💜 Thank you to everyone who walked, donated, and made an impact. @PanCANRD @UNCPancreas @derlabunc @YPGlab @bryant_kl
Our PANcreatic adenocarcinoma with Gemcitabine, Erlotinib, and nAb-paclitaxel (PANGEA) trial is now recruiting #pancreaticcancer patients to test this combination treatment in advanced unresectable or metastatic basal-like subtype PDAC @theNCI @CD_AACR go.unc.edu/Aa37Y
The NIH reduces its maximum indirect rate for research from 60% to 15% with immediate effect.
More than 60 leading researchers gathered at the 2025 GI SPORE Annual Investigators Meeting, hosted by UNC Lineberger, to exchange groundbreaking insights on pancreatic cancer research. This collaborative effort, supported by the GI SPORE, is driving progress toward better…
If you are the first or corresponding author of a 2023 or 2024 @CD_AACR paper, Assistant Professor or equivalent, and have received your PhD/MD in the past 12 years - apply! The deadline is January 10!
Reminder—nominations for the Cancer Discovery Early Career Award are open until January 10, 2025. Submit a nomination today! bit.ly/49X5BzG